IMMUNOVANT INC's ticker is IMVT and the CUSIP is 45258J102. A total of 114 filers reported holding IMMUNOVANT INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $600,000 | -11.6% | 107,498 | -38.2% | 0.26% | -11.1% |
| Q2 2022 | $679,000 | -12.3% | 174,000 | +23.8% | 0.29% | -1.7% |
| Q1 2022 | $774,000 | -35.3% | 140,500 | 0.0% | 0.29% | -32.9% |
| Q4 2021 | $1,197,000 | -2.0% | 140,500 | 0.0% | 0.44% | -7.2% |
| Q3 2021 | $1,221,000 | +80.6% | 140,500 | +119.5% | 0.47% | +72.4% |
| Q2 2021 | $676,000 | – | 64,000 | – | 0.27% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RTW INVESTMENTS, LP | 7,510,412 | $264,291,000 | 6.36% |
| Ghost Tree Capital, LLC | 525,000 | $18,475,000 | 5.34% |
| Pinz Capital Management, LP | 199,100 | $7,006,000 | 2.56% |
| ACUTA CAPITAL PARTNERS, LLC | 250,000 | $8,798,000 | 2.39% |
| BVF INC/IL | 1,198,427 | $42,173,000 | 2.30% |
| Cormorant Asset Management, LP | 1,637,951 | $57,639,000 | 2.22% |
| Vivo Capital, LLC | 1,042,460 | $36,684,000 | 2.12% |
| Parkman Healthcare Partners LLC | 150,151 | $5,284,000 | 1.40% |
| MANGROVE PARTNERS IM, LLC | 230,307 | $8,105,000 | 1.02% |
| Ikarian Capital, LLC | 321,887 | $11,328,000 | 0.82% |